Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

SIGLEC7 Antikörper (AA 377-467)

Dieses Anti-SIGLEC7-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von SIGLEC7 in WB, IHC, ELISA und IF. Geeignet für Human.
Produktnummer ABIN7169566

Kurzübersicht für SIGLEC7 Antikörper (AA 377-467) (ABIN7169566)

Target

Alle SIGLEC7 Antikörper anzeigen
SIGLEC7 (Sialic Acid Binding Ig-Like Lectin 7 (SIGLEC7))

Reaktivität

  • 96
  • 11
  • 6
  • 3
  • 2
  • 2
  • 1
  • 1
Human

Wirt

  • 63
  • 33
  • 1
Kaninchen

Klonalität

  • 62
  • 32
  • 2
Polyklonal

Konjugat

  • 57
  • 10
  • 9
  • 6
  • 5
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser SIGLEC7 Antikörper ist unkonjugiert

Applikation

  • 73
  • 45
  • 37
  • 24
  • 19
  • 18
  • 9
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Western Blotting (WB), Immunohistochemistry (IHC), ELISA, Immunofluorescence (IF)
  • Bindungsspezifität

    • 9
    • 8
    • 6
    • 5
    • 4
    • 4
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 377-467

    Kreuzreaktivität

    Human, Maus

    Aufreinigung

    >95%, Protein G purified

    Immunogen

    Recombinant Human Sialic acid-binding Ig-like lectin 7 protein (377-467AA)

    Isotyp

    IgG
  • Applikationshinweise

    Recommended dilution: WB:1:500-1:5000, IHC:1:20-1:200, IF:1:50-1:200,

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C,-80 °C

    Informationen zur Lagerung

    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Target

    SIGLEC7 (Sialic Acid Binding Ig-Like Lectin 7 (SIGLEC7))

    Andere Bezeichnung

    SIGLEC7

    Hintergrund

    Background: Putative adhesion molecule that mediates sialic-acid dependent binding to cells. Preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acid. Also binds disialogangliosides (disialogalactosyl globoside, disialyl lactotetraosylceramide and disialyl GalNAc lactotetraoslylceramide). The sialic acid recognition site may be masked by cis interactions with sialic acids on the same cell surface. In the immune response, may act as an inhibitory receptor upon ligand induced tyrosine phosphorylation by recruiting cytoplasmic phosphatase(s) via their SH2 domain(s) that block signal transduction through dephosphorylation of signaling molecules. Mediates inhibition of natural killer cells cytotoxicity. May play a role in hemopoiesis. Inhibits differentiation of CD34+ cell precursors towards myelomonocytic cell lineage and proliferation of leukemic myeloid cells (in vitro).

    Aliases: Adhesion inhibitory receptor molecule 1 antibody, Adhesion inhibitory receptor molecule 1, siglec 7 antibody, AIRM 1 antibody, AIRM-1 antibody, AIRM1 antibody, CD328 antibody, CD328 antigen antibody, CDw328 antibody, D siglec antibody, D-siglec antibody, HLDA 8 antibody, p75 antibody, p75/AIRM1 antibody, QA79 antibody, QA79 membrane protein antibody, Sialic acid binding Ig like lectin 7 antibody, Sialic acid binding immunoglobulin like lectin 7 antibody, Sialic acid-binding Ig-like lectin 7 antibody, SIGL7_HUMAN antibody, Siglec-7 antibody, SIGLEC19P antibody, SIGLEC7 antibody, SIGLECP2 antibody

    UniProt

    Q9Y286
Sie sind hier:
Chat with us!